EV mobility platform ZEVO India is infusing Rs 240 crore into its business to strengthen its presence in the Indian logistics market, its top executive told ETAuto. "We are raising about Rs 240 ...

In January and February of this year, the US Food and Drug Administration granted approvals for Adcetris (brentuximab vedotin), Lumakras (sotorasib), Grafapex (treosulfan), Enhertu (fam ...

What is the Moab 240? Founded in 2017, the Moab 240 was created in memory of ultrarunner Stephen Jones, who tragically died in 2016 in an avalanche while skiing. A much-loved figure in Utah trail ...

This design is broader than the currently approved KRAS inhibitors, Amgen's Lumakras (sotorasib) and Bristol Myers Squibb's Krazati (adagrasib), which target only the "off" state of KRAS G12C. "While ...